Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 4/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | FGFR1 | P11362 | 3/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.40 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.40 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23266636 | 0.85 | HTT (0.60) | HTTPOLBFGFR1ALDH1A1ROCK1 | |
| SCHEMBL3417306 | 0.79 | HTT (0.73) | HTTPOLBFGFR1ALDH1A1ROCK1 | |
| SCHEMBL27995809 | 0.79 | HTT (0.58) | HTTPOLBFGFR1MAPK1ALDH1A1 | |
| SCHEMBL23266681 | 0.79 | HTT (0.53) | HTTPOLBFGFR1ALDH1A1ROCK1 | |
| SCHEMBL21135010 | 0.78 | HTT (0.49) | HTTPOLBFGFR1MAPK1ALDH1A1 | |
| SCHEMBL13504641 | 0.75 | POLB (0.57) | HTTPOLBFGFR1ALDH1A1ROCK1 | |
| SCHEMBL23266691 | 0.75 | HTT (0.53) | HTTPOLBFGFR1ALDH1A1KDM4E | |
| SCHEMBL25635315 | 0.75 | HTT (0.49) | HTTPOLBFGFR1ALDH1A1ROCK1 | |
| SCHEMBL30389764 | 0.75 | HTT (0.49) | HTTPOLBFGFR1ALDH1A1ROCK1 | |
| SCHEMBL5937 | 0.75 | HTT (0.56) | HTTPOLBFGFR1ALDH1A1ROCK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10818850-B2 | Organic electroluminescence device and compound including nitrogen for organic electroluminescence device | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-10-27 | — | — | US | disclosed |
| US-20190198773-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND COMPOUND INCLUDING NITROGEN FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190198773-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND COMPOUND INCLUDING NITROGEN FOR ORGANIC ELECTROLUMINESCENCE DEVICE | L1CAM, CHRM1, FOXM1 | HTT 4014/4885POLB 2783/4885FGFR1 1828/4885 |
| US-10818850-B2 | Organic electroluminescence device and compound including nitrogen for organic electroluminescence device | L1CAM, CHRM1, FOXM1 | HTT 4014/4885POLB 2783/4885FGFR1 1828/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.